Replies to post #579 on SCYNEXIS (SCYX)

[dabonenose]

SCYX just isn't getting any respect right now, but the numbers are decent and the prospects are very good.

Here is ananalysis of their numbers against their peers.

Note*** Their peers are trading at $47 and $27 per share against SCYX $1.68.

In time I think SCYX will adjust to a more inline valuation.

Note*** In some of the categories, SCYX is doing better than their peers.

http://www.capitalcube.com/blog/index.php/scynexis-inc-scyx-us-earnings-analysis-q1-2017-by-the-numbers-may-12-2017/?yptr=yahoo